DionyMed Stops Trading, Heads For Bankruptcy

DionyMed Brands Inc. (CSE: DYME; OTCQB: DYMEF) is headed to bankruptcy. The cannabis company had been unable to meet the demands of its creditors and announced today it was unable to attract a viable transaction to restructure its debts. The company also said tried to seek a sale of its assets outside of a court process.

GLAS America (the company’s creditor) has therefore advised the company that it intends to proceed with the Receivership Application and DionyMed said it does not intend to oppose the appointment of a receiver. The company anticipates that FTI Consulting Canada Inc. will be appointed as a receiver at the hearing of the Receivership Petition or shortly thereafter.

DionyMed’s four directors Susan Watt, David Kerr, Brett Moyer and Stephen Dineley have advised the company that they intend to resign effective upon the appointment of the receiver.

It was previously announced that GLAS USA LLC  and GLAS America LLC, under the company’s credit agreement dated January 16, 2019  provided the Company with notice of default under the Credit Agreement and demand for immediate payment of the amount of $24 million-plus any additional interest, fees and expenses and that GLAS America served the Company with a petition to the Supreme Court of British Columbia seeking the appointment of a receiver over all of the Company’s property and assets.

On September 23, Flow Capital began legal proceedings against Dionymed saying they were in default under the company’s royalty agreement.  The claim is for the minimum sum of $2,698,116 which is made up of the investment balance, past due royalty payments and late payment fees.  The company’s investment in DionyMed is $1,000,000 and there can be no assurance that the Company will recover any portion of its investment.

Just last month, Dionymed announced an additional investment from its senior secured investor of $3.2MM and a reorganization of the business to right-size the company. “This increases the credit facility with the senior lender to US$19.2 MM. The credit facility bears interest at LIBOR (at a floor of 2.5%) plus 12% plus an anniversary fee of 2.5%, maturing February 6, 2021. While the credit facility is currently in default, the senior lender has agreed to make additional advances to the Company.”

Debra Borchardt

Debra BorchardtDebra Borchardt

Debra Borchardt is the CEO, Co-Founder, and Editor-In-Chief of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Masters degree in Business Journalism from New York University.


Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 21 hours

$ACRG ⁦@AcreageCannabis⁩ Buys New Jersey’s Compassionate Care For Undisclosed Amount. Co trailed competition but ga…

@GreenMarketRpt – 21 hours

⁦@medmen⁩ $MMNFF $MMEN Faces Reality, Slashes Employees, Scales Back Expansion

Back to Top

You have Successfully Subscribed!